Moreover, GMB and its metabolites have regulatory effects on the NLRP3 inflammasome, and dysbacteriosis will cause activation of the NLRP3 inflammasome, which will further aggravate inflammation or myocardial fibrosis [42,43]. This evidence concerns the gene NLRP3 and Myocardial fibrosis.